Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNAs (miRNAs) play crucial roles in gene regulation and are implicated in cancer development.
• Understanding miRNA targets is key to deciphering their contribution to the malignant phenotype of breast cancer.

Purpose of the Study:

• To identify and characterize the targets of dysregulated microRNAs in breast cancer.
• To investigate the role of miR-205 in regulating the high mobility group box 3 (HMGB3) gene in breast cancer cells.

Main Methods:

• Expression analysis of miR-205 in breast cancer cell lines and tissues.
• Bioinformatic prediction and experimental validation (dual-luciferase reporter assay, Western blotting) of miR-205 binding to HMGB3.
• Functional assays (proliferation, invasion) in breast cancer cells treated with miR-205 mimics or HMGB3 siRNA.
• Analysis of HMGB3 expression in patient samples and correlation with survival.
• Investigating the regulatory mechanisms of miR-205 and HMGB3 expression using 5-Aza/TSA and NRSF/REST knockdown.

Main Results:

• miR-205 expression was significantly reduced in breast cancer cell lines and tissues compared to normal controls.
• HMGB3 was identified as a direct target of miR-205, with miR-205 negatively regulating HMGB3 expression.
• Overexpression of miR-205 or knockdown of HMGB3 suppressed breast cancer cell proliferation and invasion.
• Higher HMGB3 levels in tumors correlated with poorer patient survival.
• Epigenetic modulation (5-Aza/TSA) and NRSF/REST knockdown affected miR-205 and HMGB3 expression levels.

Conclusions:

• miR-205 directly targets and regulates HMGB3 in breast cancer.
• The miR-205/HMGB3 axis plays a significant role in controlling breast cancer cell proliferation and invasion.
• Targeting HMGB3 or restoring miR-205 levels represents a promising therapeutic strategy for advanced breast cancer.